Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 55%
Date: 02-04-2026
Price: $0.046
Last Price: $0.059
Post-Signal Peak Price: $0.075
The Australian market recently experienced a dip, with the ASX down 0.3% as investors awaited key CPI data and closely monitored geopolitical developments, such as the US-China diplomatic talks. In this environment of cautious optimism and sector fluctuations, identifying high-growth tech stocks req
Immutep Limited Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to conduct the futility analysis Over 100 clinical sites across 24 countries now activated and open for recruitment Futility analysis remains on
As the Australian market navigates a fluctuating landscape, with the S&P/ASX 200 Index recently flirting with 8,860 points and foreign direct investment outflows heading back to the US, investors are keenly evaluating high-growth opportunities amid shifting sentiments. In this context, identifying p
Immutep Limited SYDNEY, AUSTRALIA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces it has received positive and constructive feedback from the US Foo
Immutep Limited SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for the pivotal TACTI-004 (KEYNOTE
AI Confidence - 55 % model confidence
Immutep Limited is a clinical-stage biotechnology company focused on the development of novel immunotherapies for cancer and autoimmune diseases. It holds a strong position in the immuno-oncology sector with its proprietary LAG-3 technology platform, targeting immune checkpoint pathways to enhance cancer treatment efficacy.
| Cash Flow | Weak |
| Debt | Low |
| Profitability | Weak |
| Revenue Trend | Unknown |
| Trend | Bullish |
| Momentum | Moderate |
| RSI Signal | Neutral |
| Support Level | $ 0.0400 |
| Resistance Level | $ 0.0550 |